# Development of a WT RNAP-based kit for high-yield synthesis of chemically modified RNA

> **NIH NIH R43** · DOTQUANT, LLC · 2024 · $305,892

## Abstract

ABSTRACT
With the growing number of RNA therapeutics approved for clinical uses and the fundamental advantages of
using RNA in regulating protein expression, vaccines, genome editing, and targeting ligands, RNA has attracted
substantial recent interest from both academic institutions and the pharmaceutical industry. Unless the RNA
sequences of interest are very short (< 60 bp), in vitro transcription is often the desired approach for synthesis.
Due to their inherent instability against enzyme degradation, RNAs for use in biotechnology and medicine require
chemical modifications. Conventional T7 RNA polymerase (T7RNAP) is highly efficient in making long RNAs,
but it has been difficult to incorporate chemically modified nucleotides. In contrast, T7RNAP mutants can
incorporate chemically modified nucleotides but the yields of transcription are significantly lower, driving up the
costs for both biomedical research and healthcare. By investigating the key parameters that influence T7RNAP
activity, we have identified the barriers that hinder wild-type T7RNAP from accepting modified substrates and
developed formulations and protocols to address them. Based on these innovations, here, we propose to develop
a new in vitro transcription kit that combines the benefits of both worlds, the high efficiency and low cost of wild-
type T7RNAP, and the tolerance of modified nucleotides of mutant T7RNAPs. This kit will generate chemical-
modified serum-stable RNAs with a minimum 10-fold increase in yield over current best-performing kits, thus
drastically improving the affordability of current and future RNA drugs.

## Key facts

- **NIH application ID:** 11005990
- **Project number:** 1R43GM151884-01A1
- **Recipient organization:** DOTQUANT, LLC
- **Principal Investigator:** Hong Yan Liu
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $305,892
- **Award type:** 1
- **Project period:** 2024-08-10 → 2026-02-09

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11005990

## Citation

> US National Institutes of Health, RePORTER application 11005990, Development of a WT RNAP-based kit for high-yield synthesis of chemically modified RNA (1R43GM151884-01A1). Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/grant/nih/11005990. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*